Risks
4 risks
Risk Intelligence
Unseasonal rains impacting crop protection
View Risks →Godrej Agrovet Limited — Q3 FY26
Godrej Agrovet delivered a strong Q3 FY26 with consolidated revenues growing 11% YoY and profit before tax up 23% YoY (before exceptional items).
bullish
high
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
Godrej Agrovet delivered a strong Q3 FY26 with consolidated revenues growing 11% YoY and profit before tax up 23% YoY (before exceptional items). The performance was driven by margin expansion, operational efficiencies, and robust contributions from vegetable oil, animal feed, poultry, and processed foods, alongside a sharp turnaround in Astec Life Sciences. Animal feed volumes grew 12% YoY, with cattle feed up 21%, while vegetable oil revenue rose 27% on higher fresh fruit bunch arrivals and record oil extraction ratio of 21%. Astec Life Sciences turned EBITDA positive at ₹5 crore, a sharp improvement from a loss last year. Management guided for continued momentum, with Astec targeting 15% revenue growth in FY27 and the crop protection business diversifying into new products. A strategic portfolio review is underway, with communication expected by early April. Key risks include unseasonal rains impacting crop protection and sustained milk procurement cost inflation in dairy.
गोदरेज एग्रोवेट ने वित्त वर्ष 2026 की तीसरी तिमाही में शानदार प्रदर्शन किया। कंपनी की कुल कमाई पिछले साल की तुलना में 11% बढ़ी, और कर से पहले मुनाफा 23% बढ़ा (एक बार के खर्चों को छोड़कर)। यह मुनाफा बढ़ने, कामकाज में सुधार और वनस्पति तेल, पशु आहार, पोल्ट्री और प्रसंस्कृत खाद्य के मजबूत योगदान से हुआ। पशु आहार की बिक्री 12% बढ़ी, जिसमें गाय के चारे की बिक्री 21% बढ़ी। वनस्पति तेल की कमाई 27% बढ़ी। एस्टेक लाइफ साइंसेज ने घाटे से उबरकर 5 करोड़ रुपये का मुनाफा कमाया। कंपनी अब नए उत्पादों पर ध्यान दे रही है। हालांकि, बेमौसम बारिश और दूध की बढ़ती लागत जोखिम हैं।
Risks4 trackedTranscriptfull text
Research workspace
Focused Modules
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Cattle Feed Volume Growth
21%
+21% YoY
Cattle feed volumes grew 21% YoY in Q3, contributing to overall animal feed volume growth of 12%.
Oil Extraction Ratio (OER)
21%
+30bps YoY
Record OER of 21% in Q3, up from 20.7% in Q3 last year, driven by operational efficiencies.
Astec EBITDA
₹5 Cr
Positive vs loss YoY
Astec Life Sciences turned EBITDA positive at ₹5 crore, a sharp improvement from a loss in Q3 FY25.
Branded Salience in Foods
81%
+4pp YoY
Branded salience in the foods business rose to 81% from 77% last year, driven by focus on value-added products.
Fast read
Guidance and risk preview
Management targets 15% revenue growth for Astec in FY27, led by CDMO segment growing faster than enterprise.
Unseasonal rains and cyclones in Q3 affected crop protection volumes, and a base effect from co-marketing herbicide sales will impact Q4.
View Risks →